The role and activities of the Health Emergency preparedness and Response Authority (HERA) DG

Abstract HERA was established in 2021 as a key pillar of the European Health Union with the aim of strengthening the EU's capacity to prevent, detect, and respond rapidly to serious cross-border health threats. Born from the lessons of the COVID-19 pandemic, HERA plays a central role in ensuring the development, availability, accessibility, and equitable distribution of medical countermeasures (MCMs)-including vaccines, therapeutics, diagnostics, and personal protective equipment-across the entire value chain. HERA operates across the full preparedness and response cycle. In the preparedness phase, it conducts intelligence gathering, threat assessments, and maps MCM availability and needs, while supporting research, innovation, manufacturing, and procurement. During crises, HERA and its Health Crisis Board play a key role in the EU's health emergency response by coordinating MCM procurement, monitoring, and deployment from EU strategic reserves, fostering research, and activating mechanisms such as the EU FAB network. HERA's governance structure includes: (a) the HERA Board-composed of Commission experts and senior Member State representatives-which sets strategic objectives; and (b) the HERA Advisory Forum, a technical body of national experts providing advice. These are supported by the Joint Industrial Cooperation Forum (e.g. vaccine manufacturers) and the CSF (e.g. patient associations, scientific societies relevant to HERA's scope, NGOs). EUPHA has participated in the closed sessions of the CSF HERA since its inception, in the concerted collaboration effort to coalesce for strategic alignment across EU MS, EU agencies, international partners, academia, industry, and civil society- and for fostering research through EU4Health, Horizon Europe, and the Union Civil Protection Mechanism, and coordinating capacity-building and preparedness exercises. Speakers/Panellists Maria Gańczak Department of Infectious Diseases, University of Zielona Gora, Zielona Gora, Poland Dimitra Lingri National Organization for Health Care Services Provision/Lawyer, Athens Greece, Greece Neville Calleja Department of Health Information and Research, G'Mangia, Malta

Institutions

Publication Details

Journal
European Journal of Public Health
Published
2025-10-01
DOI
https://doi.org/10.1093/eurpub/ckaf161.217
Primary Topic
Global Security and Public Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The role and activities of the Health Emergency preparedness and Response Authority (HERA) DG

European Journal of Public Health
Global Security and Public Health
article

The role and activities of the Health Emergency preparedness and Response Authority (HERA) DG

article en

Abstract

Abstract HERA was established in 2021 as a key pillar of the European Health Union with the aim of strengthening the EU's capacity to prevent, detect, and respond rapidly to serious cross-border health threats. Born from the lessons of the COVID-19 pandemic, HERA plays a central role in ensuring the development, availability, accessibility, and equitable distribution of medical countermeasures (MCMs)-including vaccines, therapeutics, diagnostics, and personal protective equipment-across the entire value chain. HERA operates across the full preparedness and response cycle. In the preparedness phase, it conducts intelligence gathering, threat assessments, and maps MCM availability and needs, while supporting research, innovation, manufacturing, and procurement. During crises, HERA and its Health Crisis Board play a key role in the EU's health emergency response by coordinating MCM procurement, monitoring, and deployment from EU strategic reserves, fostering research, and activating mechanisms such as the EU FAB network. HERA's governance structure includes: (a) the HERA Board-composed of Commission experts and senior Member State representatives-which sets strategic objectives; and (b) the HERA Advisory Forum, a technical body of national experts providing advice. These are supported by the Joint Industrial Cooperation Forum (e.g. vaccine manufacturers) and the CSF (e.g. patient associations, scientific societies relevant to HERA's scope, NGOs). EUPHA has participated in the closed sessions of the CSF HERA since its inception, in the concerted collaboration effort to coalesce for strategic alignment across EU MS, EU agencies, international partners, academia, industry, and civil society- and for fostering research through EU4Health, Horizon Europe, and the Union Civil Protection Mechanism, and coordinating capacity-building and preparedness exercises. Speakers/Panellists Maria Gańczak Department of Infectious Diseases, University of Zielona Gora, Zielona Gora, Poland Dimitra Lingri National Organization for Health Care Services Provision/Lawyer, Athens Greece, Greece Neville Calleja Department of Health Information and Research, G'Mangia, Malta

European Journal of Public HealthVol. 35(Supplement_4)
European Commission (BE), Directorate-General for Research and Innovation (BE)
Partnerships for the goals
Openalex Percentile: Top 35%
Global Security and Public Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.